SIMPLEX TRADING, LLC - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 40 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$026,210
+7120.4%
0.00%
Q3 2020$0
-100.0%
363
-86.3%
0.00%
Q4 2019$42,000
+4100.0%
2,644
+2570.7%
0.00%
Q3 2019$1,000
-96.4%
99
-94.2%
0.00%
Q2 2019$28,000
-56.9%
1,704
-55.2%
0.00%
Q1 2019$65,000
+18.2%
3,803
+21.7%
0.00%
Q4 2018$55,000
+685.7%
3,125
+656.7%
0.00%
Q3 2018$7,000
+40.0%
413
+56.4%
0.00%
Q2 2018$5,000
-85.7%
264
-86.9%
0.00%
-100.0%
Q1 2018$35,000
+29.6%
2,022
-17.4%
0.00%
+100.0%
Q4 2017$27,0002,448
+8966.7%
0.00%
Q3 2015$0270.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q3 2018
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 40,000$734,0000.83%
WATER ISLAND CAPITAL LLC 133,286$2,444,0000.21%
Walleye Capital LLC 90,666$1,663,0000.18%
GLAZER CAPITAL, LLC 202,158$3,708,0000.18%
First Trust Capital Management L.P. 35,613$653,0000.18%
EQUITEC PROPRIETARY MARKETS, LLC 12,500$229,0000.18%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$194,0000.15%
Olympiad Research LP 13,484$247,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.10%
Alpine Global Management, LLC 25,000$459,0000.10%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders